Citigroup’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
Other funds holding CLOV
Citigroup's CLOV Position: Q3 2026 in Review
Citigroup reduced its Clover Health Investments (CLOV) stake by 78% in Q3 2026, selling an estimated $781K and leaving 49,041 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #4185.
Citigroup first reported a position in CLOV in Q4 2020 and has held it in 24 quarters since. The position peaked at $3.02M in Q4 2021. 230 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.
- Citigroup held 49,041 shares of Clover Health Investments worth $211K as of Q3 2026.
- Citigroup sold 174,224 Clover Health Investments shares in Q3 2026, an estimated $781K.
- Clover Health Investments made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4185 holding.
- Citigroup first reported a position in Clover Health Investments in Q4 2020 and has held it in 24 quarters since.
- Citigroup's Clover Health Investments position peaked at $3.02M in Q4 2021.
- 230 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.